Table 1.

Clinical features of all study patients with lymphoepithelioma-like hepatocellular carcinoma

Case (ref)	Age (year)	sex	race	EBV	HBV	HCV	liver cirrhosis	tumor number	tumor size (cm)	surgery	preo/postoperative therapy	recur rence	survival	OS (month)
1 [6]	50	M	W	N	P	P	Yes	1	4.0	LT	Yes	No	AWND	120
2 [6]	54	M	W	N	N	N	No	Multi	2.0	LT	No	Yes	DD	92.4
3 [6]	59	M	W	N	P	P	Yes	Multi	5.0	LT	Yes	No	AWND	96
4 [6]	45	M	W	N	N	P	Yes	1	2.0	LT	Yes	No	AWND	56.4
5 [6]	64	M	W	N	N	N	Yes	M	4.0	LT	Yes	No	AWND	36
6 [7]	39	F	W	P	N	P	Yes	1	1.0	LT	Yes	Yes	DD	5
7[8]	56	M	Y	N	N	P	Yes	1	3.0	LR	Yes	Yes	DD	21
8 [9]	47	F	W	N	N	N	No	1	2.2	LR	No	Yes	AWD	15
9 [10]	57	M	Y	N	P	N	Yes	1	2.7	LR	No	No	AWND	50
10 [11]	79	M	Y	U	N	N	No	1	4.2	LR	Yes	Yes	AWD	20
11 [12]	74	F	W	N	N	N	No	Multi	6.5	LR+LND	Yes	Yes	DD	24
12 [12]	65	M	W	N	N	N	No	1	4.8	LR	Yes	No	DUC	60
13 [12]	65	F	W	N	N	N	No	1	1.3	LR	Yes	Yes	AWD	108
14 [12]	70	F	W	N	N	N	No	1	2.7	LR	Yes	No	AWND	72
15 [12]	61	F	W	N	N	N	No	Multi	9.5	LR	Yes	No	AWND	4
16 [12]	78	M	W	N	N	N	No	1	10.5	LR	Yes	Yes	DUC	48
17 [12]	78	F	W	N	N	N	No	1	6	LR	Yes	No	AWND	24
18 [12]	57	F	W	N	N	N	No	1	13	LR	Yes	No	DUC	1
19	50	M	Y	N	P	N	Yes	1	3	LR+LND	Yes	No	AWD	6

M, male; F, female; W, white from Europe and the United States; Y, yellow from East Asia; N, negative; P, positive; U, unknown; Multi, Multifocal; LT, Liver transplantation; LR, Liver resection; LND, resection of the swollen lymph node; AWND, alive with no disease; AWD, alive with disease; DD, died disease; DUC, died of unrelated cause.